Cannabinoid Receptor
Cannabinoid receptors are GPCRs that mediate the effects of endogenous cannabinoids (endocannabinoids) and phytocannabinoids, such as those found in cannabis. The two main types of cannabinoid receptors, CB1 and CB2, are involved in regulating a wide range of physiological processes, including pain perception, appetite, mood, and immune function. Cannabinoid receptor modulators have therapeutic potential in treating conditions such as chronic pain, epilepsy, and multiple sclerosis. At CymitQuimica, we offer a wide range of high-quality cannabinoid receptor modulators to support your research in neuropharmacology, pain management, and immunology.
Found 196 products of "Cannabinoid Receptor"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
TC-C 14G
CAS:<p>CB1 receptor inverse agonist</p>Formula:C24H17Cl2F2NO4Purity:98%Color and Shape:SolidMolecular weight:492.3ZCZ011
CAS:<p>ZCZ011 enhances CB1 receptor effects, crosses blood-brain barrier, and potentiates cannabimimetic behaviors in mice.</p>Formula:C21H18N2O2SPurity:98%Color and Shape:SolidMolecular weight:362.44(S)-SLV 319
CAS:<p>Ibipinabant (SLV319), a potent CB1 antagonist, K i = 7.8 nM, >1000x selective over CB2, for obesity and diabetic research.</p>Formula:C23H20Cl2N4O2SColor and Shape:SolidMolecular weight:487.4COR167
CAS:<p>COR167 is a CB2 agonist with immunomodulatory effects, protective brain properties, and antinociception.</p>Formula:C28H38N2O2Color and Shape:SolidMolecular weight:434.61CID1172084
CAS:<p>CID1172084, a novel high-potent GPR55 agonist, interacts with cannabinoid receptors.</p>Formula:C23H18FN5O2S2Color and Shape:SolidMolecular weight:479.55O-2093
CAS:<p>anandamide uptake inhibitor</p>Formula:C34H43Cl2NO3Purity:98%Color and Shape:SolidMolecular weight:584.62GAT228
CAS:<p>GAT228, an allosteric ligand for the cannabinoid receptor 1 (CB1), functions as the enantiomer of GAT211 [1].</p>Formula:C22H18N2O2Color and Shape:SolidMolecular weight:342.39CB1 inverse agonist 2
CAS:<p>CB1 inverse agonist 2, an oral drug, counters CB1 effects, reducing CP55940-induced hypothermia and anorexia in mice.</p>Formula:C24H20ClFN2OSColor and Shape:SolidMolecular weight:438.94CB2R agonist 1
CAS:<p>CB2R agonist 1 selectively binds human CB2R, EC50 of 0.56 µM, modulates inflammatory cytokines.</p>Formula:C22H32N2OColor and Shape:SolidMolecular weight:340.5LEI 101 hydrochloride
CAS:<p>LEI 101 hydrochloride is potent and selective CB2 partial agonist.</p>Formula:C23H26ClFN4O4SColor and Shape:SolidMolecular weight:508.99ANEB-001
CAS:<p>ANEB-001 is an orally active CB1 inhibitor that can be used in studies of acute cannabinoid intoxication.</p>Formula:C22H24ClF3N2O2Color and Shape:SolidMolecular weight:440.89CB1R Allosteric modulator 2
CAS:<p>Compound 18 is a potent CB1R allosteric modulator that acts as a negative modulator (NAM) for CB1R orthosteric ligands.</p>Formula:C19H15ClFN3OColor and Shape:SolidMolecular weight:355.79COR 170
CAS:<p>inverse agonist of CB2 receptors</p>Formula:C31H36N2O2Purity:98%Color and Shape:SolidMolecular weight:468.63CB1/2 agonist 2
CAS:<p>CB1/2 agonist 2 binds tightly to cannabinoid receptors, acting fully on CB1 and inversely on CB2.</p>Formula:C26H43NO3Color and Shape:SolidMolecular weight:417.62PGN36
CAS:<p>PGN36 (Compound 18) is a potent CB2 receptor antagonist with a high affinity (Ki=0.09 μM).</p>Formula:C21H23N3O3Color and Shape:SolidMolecular weight:365.43CB1R Allosteric modulator 1
CAS:<p>CB1R modulator 1 (compound 11), a potent CB1R inhibitor, decreases activity of orthosteric ligands.</p>Formula:C24H24ClN3OColor and Shape:SolidMolecular weight:405.92S-777469
CAS:<p>S-777469: Selective CB2 agonist, oral, inhibits itching in mice (Ki: 36 nM). Anti-pruritic.</p>Formula:C23H27FN2O4Color and Shape:SolidMolecular weight:414.47CB2 receptor agonist 3
CAS:<p>GP 2A is a selective agonist of CB2 receptor.</p>Formula:C24H23Cl2N3OColor and Shape:SolidMolecular weight:440.36Virodhamine trifluoroacetate
CAS:<p>Virodhamine trifluoroacetate: full GPR55 & CB2 agonist, partial CB1 antagonist, cannabinoid receptor mixed antagonist.</p>Formula:C24H38F3NO4Purity:98%Color and Shape:SolidMolecular weight:461.56LBP-1
CAS:<p>LBP-1 is a cannabinoid receptor type 1 (CB1) agonist.</p>Formula:C23H29ClN6O3Color and Shape:SolidMolecular weight:472.97MM-22
CAS:<p>biotinylated anandamide analog acts as a probe for visualizing the accumulation and intracellular trafficking of anandamide</p>Formula:C36H60N4O5SPurity:98%Color and Shape:SolidMolecular weight:660.95KLS-13019
CAS:<p>KLS-13019 is a highly effective and orally active GPR55 receptor antagonist, neuroprotective can reverse chemotherapy-induced peripheral neuropathy (CIPN).</p>Formula:C22H29NO3Purity:>99.99% - >99.99%Color and Shape:SolidMolecular weight:355.47OMDM-6
CAS:<p>OMDM-6 is a dual agonist of TRPV1(EC50 = 75 nM) and CB1 (Ki = 3.2 μM). OMDM-6 inhibits anandamide cellular uptake with a Ki of 7.0 μM.</p>Formula:C28H42N2O3Purity:99.66%Color and Shape:SolidMolecular weight:454.64N-Arachidonyldopamine
CAS:<p>N-Arachidonyldopamine (NADA) is a selective and potent endogenous CB1 receptor agonist (Ki: 250 nM).N-Arachidonyldopamine is also a potent and selective TRPV1</p>Formula:C28H41NO3Purity:97.65%Color and Shape:SolidMolecular weight:439.63CB2 modulator 1
CAS:<p>CB2 modulator 1 is a potent CB2 modulator. It can be used for the research for immune disorders, osteoporosis, inflammation, renal ischemia.</p>Formula:C18H19F3N4O2Purity:99.6%Color and Shape:SolidMolecular weight:380.36AM6545
CAS:<p>AM6545 is a CB1 receptor antagonist used in the study of obesity and diabetes.</p>Formula:C26H23Cl2N5O3SPurity:97.03%Color and Shape:SolidMolecular weight:556.46Arvanil
CAS:<p>Arvanil (N-Vanillylarachidonamide) is a synthetic capsaicin-amphetamine hybrid that acts as a ligand for VR1 and CB1, offering neuroprotective effects.</p>Formula:C28H41NO3Purity:99.49%Color and Shape:SolidMolecular weight:439.63MJ 15
CAS:<p>MJ 15 is a CB1 receptor antagonist with specificity for the study of obesity-induced diseases.</p>Formula:C23H17Cl3N4OPurity:99.63%Color and Shape:SolidMolecular weight:471.77AZD1940
CAS:<p>AZD1940 (UNII-0J0035E9FT) is a high affinity CB(1)/CB(2) receptor agonist of the cannabinoid with oral activity. Application in the study of orofacial pain.</p>Formula:C20H29F2N3O2SPurity:98.68%Color and Shape:SolidMolecular weight:413.52JTE-907
CAS:<p>JTE-907 是一种具有高度选择性和口服活性的 CB2 受体反向激动剂。JTE-907在体内展现出抗炎活性。</p>Formula:C24H26N2O6Purity:99.93%Color and Shape:SolidMolecular weight:438.47CB1 agonist 1
CAS:<p>CB1 agonist 1 is a potent CB1 agonist with a pIC50 value of 5.7 for CB1 receptors.CB1 agonist 1 can be used to study brain disorders, pain, and inflammation.</p>Formula:C24H24N2O5SPurity:98.56%Color and Shape:SolidMolecular weight:452.52SCH-336
CAS:<p>SCH-336: potent, selective CB2 agonist (Ki=1.8 nM, EC50=2 nM), orally active, 100x CB2 vs. CB1 preference, reduces leukocyte migration and eosinophilia.</p>Formula:C23H25NO8S3Purity:95.01%Color and Shape:SolidMolecular weight:539.64Olorinab
CAS:<p>Olorinab (APD 371) (APD 371) is a highly potent, selective and fully efficacious cannabinoid receptor type 2 (CB2) agonist. With an EC50 of 6.2 nM for hCB2.</p>Formula:C18H23N5O3Purity:97.67% - 98.47%Color and Shape:SolidMolecular weight:357.41SR144528
CAS:<p>SR144528 is an antagonist of the CB2 receptor (Ki = 0.6 nM) and inhibits microsomal ACAT activity (IC50 = 3.6 μM).</p>Formula:C29H34ClN3OPurity:99.63%Color and Shape:SolidMolecular weight:476.05PSB-CB5
CAS:<p>PSB-CB5 (GPR18-IN-32)2 is a GRP18 antagonist with anti-inflammatory activity and can be used to study obesity and metabolic disorders.</p>Formula:C20H17ClN2O2SPurity:99.26%Color and Shape:SolidMolecular weight:384.88CB2R PAM
CAS:<p>CB2R PAM, an oral drug, boosts CB2 receptor response to specific agonists, showing potential in neuropathic pain relief.</p>Formula:C21H24BrFN2O2Purity:99.09%Color and Shape:SolidMolecular weight:435.33AM-1235
CAS:<p>AM-1235 is a potent and selective cannabinoid receptor CB1 agonist.</p>Formula:C24H21FN2O3Purity:97.77%Color and Shape:SolidMolecular weight:404.43CB1R antagonist 1
CAS:<p>CB1R antagonist 1 is a potent CB1R antagonist that can be used to study diseases related to the nervous system.</p>Formula:C18H23F3N2O3SPurity:99.65%Color and Shape:SolidMolecular weight:404.45Nonabine
CAS:<p>Nonabine is a compound with strong antiemetic properties that can be used to prevent nausea and vomiting associated with cancer chemotherapy.</p>Formula:C25H33NO2Purity:99.46% - 99.95%Color and Shape:SolidMolecular weight:379.54CAY10508
CAS:<p>CAY10508 is a potent and selective inverse agonist for the central cannabinoid (CB1) receptor with therapeutic potential for treating obesity and drug dependence, lacking psychotropic effects. It exhibits a Ki value of 243 nM and an EC50 of 195 nM. At a concentration of 10 µM, CAY10508 displaces [3H]-CP-55,940 with 100% efficacy at the CB1 receptor and 35% at the peripheral cannabinoid (CB2) receptor. Its inverse agonist activity at the CB1 receptor was confirmed through a [35S]-GTPγS binding assay.</p>Formula:C21H14Br2N2O2Color and Shape:SolidMolecular weight:486.2PF-03550096
CAS:<p>PF-03550096, an orally active synthetic cannabinoid (CB), selectively binds to peripheral CB2 receptors with a Ki value of 7.9 nM, demonstrating analgesic activity [1].</p>Formula:C19H28N4O4Color and Shape:SolidMolecular weight:376.45COR659
CAS:<p>COR659: suppresses alcohol/chocolate intake in rats; enhances GABAB receptor, blocks CB1 receptor.</p>Formula:C16H16ClNO3SPurity:99.75%Color and Shape:SolidMolecular weight:337.82CB1 antagonist 1
CAS:<p>CB1 antagonist 1 is a CB1 receptor antagonist, used in the research of obesity and metabolic syndrome, neuroinflammatory disorders, cognitive disorders, and</p>Formula:C26H22Cl2N4Purity:98%Color and Shape:SolidMolecular weight:461.39Heptadecanoyl ethanolamide
CAS:<p>Heptadecanoyl ethanolamide, an endogenous cannabinoid, serves as a synthetic analog of PEA, featuring an odd-numbered (17-carbon) fatty acid chain [1].</p>Formula:C19H39NO2Color and Shape:SolidMolecular weight:313.52AM841
CAS:<p>AM841, a high-affinity electrophilic ligand, covalently interacts with a cysteine residue in helix six, thus activating the CB1 cannabinoid receptor.</p>Formula:C26H39NO3SPurity:98%Color and Shape:SolidMolecular weight:445.66(R)-Monlunabant
CAS:<p>(R)-Monlunabant ((R)-MRI-1891) serves as a CB1 receptor antagonist utilized in obesity and metabolic disease research [1].</p>Formula:C26H22ClF3N6O3SPurity:98%Color and Shape:SolidMolecular weight:591GSK-554418A
CAS:<p>GSK-554418A, a novel azaindole CB(2) agonists, is used for the treatment of chronic pain. It is efficacious in the acute model and the chronic joint pain model.</p>Formula:C19H19ClN4O2Color and Shape:SolidMolecular weight:370.83CB 65
CAS:<p>CB 65 is a high affinity and selective CB2 receptor agonist with Ki values of 3.3 and > 1000 nM for CB2 and CB1 receptors respectively.</p>Formula:C22H28ClN3O3Purity:98.73%Color and Shape:SolidMolecular weight:417.93O-Arachidonoyl glycidol
CAS:<p>O-Arachidonoyl glycidol (compound 1), a 2-arachidonoylglycerol (2-AG) analog, effectively inhibits the hydrolysis of cytosolic 2-oleoylglycerol (2-OG) with an IC50 value of 4.5 µM, and also blocks 2-OG and anandamide hydrolysis in membrane fractions with IC50 values of 19 µM and 12 µM, respectively [1].</p>Formula:C23H36O3Color and Shape:SolidMolecular weight:360.53OMDM-5
CAS:<p>OMDM-5 is a potent vanilloid receptor type 1 (TRPV1, EC50 = 75 nM) agonist, showing weak ligand activity at cannabinoid type 1 receptor (CB1, Ki=4.9 μM).</p>Formula:C26H44N2O3Purity:99.73%Color and Shape:SolidMolecular weight:432.64
